Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28 (Q33573593)

28 July 2017

Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28 (English)

1 reference

Stéphanie Le Bas-Bernardet

28 July 2017

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Bernard Vanhove

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

5

Lyssia Belarif

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

7

Jeremy Hervouet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

8

David Minault

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

10

Vianney Charpy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

11

Gilles Blancho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Nicolas Poirier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Caroline Mary

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Veronique Daguin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Melanie Chevalier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Simon Ville

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

5 March 2014

1 reference

28 July 2017

Monoclonal Antibodies

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

697-707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release.

9 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

After TGN1412: recent developments in cytokine release assays.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

CD28-specific immunomodulating antibodies: what can be learned from experimental models?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

B7-h2 is a costimulatory ligand for CD28 in human

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

A more selective costimulatory blockade of the CD28-B7 pathway.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Primate testing of TGN1412: right target, wrong cell

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Development trends for human monoclonal antibody therapeutics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Interaction of human PD-L1 and B7-1.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Loss of Siglec expression on T lymphocytes during human evolution

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Marketed therapeutic antibodies compendium

21 June 2018

1 reference

https://api.crossref.org/works/10.4161%2FMABS.28375

Costimulation blockade with belatacept in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FMABS.28375

Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FMABS.28375

Development and homeostasis of T cell memory in rhesus macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FMABS.28375

In vitro cytokine release assays for predicting cytokine release syndrome: the current state-of-the-science. Report of a European Medicines Agency Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FMABS.28375

Comparison of novel methods for predicting the risk of pro-inflammatory clinical infusion reactions during monoclonal antibody therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FMABS.28375

Preclinical safety testing of monoclonal antibodies: the significance of species relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FMABS.28375

21 January 2018

Lessons from TGN1412.

1 reference

https://api.crossref.org/works/10.4161%2FMABS.28375

A monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safety

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4011914

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

31 October 2018

1 reference

12 December 2020

1 reference

12 December 2020

Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities

1 reference

12 December 2020

"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics

1 reference

12 December 2020

Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412

1 reference

12 December 2020

Endothelial cells co-stimulate peripheral blood mononuclear cell responses to monoclonal antibody TGN1412 in culture

1 reference

12 December 2020

ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation

1 reference

12 December 2020

Identifiers

DOI

10.4161/MABS.28375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598534%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference